» Authors » Shailaja Police

Shailaja Police

Explore the profile of Shailaja Police including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 1531
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu C, Police S, Hassanipour M, Li Y, Chen Y, Priest C, et al.
Regen Med . 2010 Dec; 6(1):53-66. PMID: 21175287
Aim: Human embryonic stem cells (hESCs) represent a novel cell source to treat diseases such as heart failure and for use in drug screening. In this study, we aim to...
2.
Laflamme M, Chen K, Naumova A, Muskheli V, Fugate J, Dupras S, et al.
Nat Biotechnol . 2007 Aug; 25(9):1015-24. PMID: 17721512
Cardiomyocytes derived from human embryonic stem (hES) cells potentially offer large numbers of cells to facilitate repair of the infarcted heart. However, this approach has been limited by inefficient differentiation...
3.
Xu C, He J, Kamp T, Police S, Hao X, OSullivan C, et al.
Stem Cells Dev . 2007 Jan; 15(6):931-41. PMID: 17253954
Current procedures for the maintenance of cardiomyocytes from human embryonic stem (hES) cells rely on either co-culture with mouse cells or medium containing fetal bovine serum (FBS). Due to exposure...
4.
Xu C, Police S, Hassanipour M, Gold J
Stem Cells Dev . 2006 Nov; 15(5):631-9. PMID: 17105398
Human embryonic stem (hES) cell-derived cardiomyocytes hold great promise for cardiovascular regenerative medicine. However, this application faces a number of challenges, including generating cardiomyocytes of adequate purity. With current protocols...
5.
Laflamme M, Gold J, Xu C, Hassanipour M, Rosler E, Police S, et al.
Am J Pathol . 2005 Aug; 167(3):663-71. PMID: 16127147
Human embryonic stem cells (hESCs) offer the opportunity to replenish cells lost in the postinfarct heart. We explored whether human myocardium could be generated in rat hearts by injecting differentiated...
6.
Xu C, Police S, Rao N, Carpenter M
Circ Res . 2002 Sep; 91(6):501-8. PMID: 12242268
Cell replacement therapy is a promising approach for the treatment of cardiac diseases, but is challenged by a limited supply of appropriate cells. We have investigated whether functional cardiomyocytes can...